Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) like semaglutide (Ozempic/Wegovy) and liraglutide (Victoza/Saxenda) were built for diabetes and obesity—but they’re increasingly being studied for brain health and systemic inflammation.
Karin, I love your new Substack. Great info but I haven't found any information on dosing for AD prevention. Is there any information out there? I've been "micro-dosing" 10-15cc once per week. Of course, there's no way to determine it's efficacy. Is there an info or anecdotal info out there?
Karin, I love your new Substack. Great info but I haven't found any information on dosing for AD prevention. Is there any information out there? I've been "micro-dosing" 10-15cc once per week. Of course, there's no way to determine it's efficacy. Is there an info or anecdotal info out there?